The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Danaher (NYSE:DHR) shares got a boost today on second-quarter results that came in well ahead of the consensus forecast.

Shares of DHR were up 7.7% at $275.61 per share in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1.3%.

The Washington, D.C.-based company posted profits of $1.7 billion, or $2.25 per share, on sales of $7.8 million for the three months ended July 1, 2022, for a 4.9% bottom-line slide on sales growth of 7.4%.

Adjusted to exclude one-time items, earnings per share were $2.76, 41¢ ahead of Wall Street, where analysts were looking for sales of $7.3 billion.

“We are pleased with our strong start to 2022,” Danaher President and CEO Rainer M. Blair said in a news release. “Our teams executed well in a challenging environment to deliver high-single-digit core revenue growth, double-digit adjusted earnings per share growth and $2.0 billion  of operating cash flow.

“We were particularly encouraged with the high-single-digit growth in our base business and believe we gained market share across the portfolio.”

Danaher said it now expects third-quarter revenue growth in the high-single-digit percent range for the third quarter, with full-year revenue growth also projected for the high-single-digit percent range.

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: danaher, Danaher Corp.

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.